Effects of Corticosteroids on Endothelial Function in Behçet's Disease
Author Information
Author(s): Protogerou Athanase D, Sfikakis Petros P, Stamatelopoulos Kimon S, Papamichael Christos, Aznaouridis Kostas, Karatzis Emmanuil, Papaioannou Theodore G, Ikonomidis Ignatios, Kaklamanis Phedon, Mavrikakis Myron, Lekakis John
Primary Institution: University of Athens
Hypothesis
How do clinical disease activity and corticosteroid treatment affect endothelial function in patients with Behçet's disease?
Conclusion
Corticosteroid treatment can impair endothelial function during remission but improves it during active disease in Behçet's disease patients.
Supporting Evidence
- Endothelial function was lower in patients with Behçet's disease compared to healthy controls.
- Corticosteroid treatment improved endothelial function in patients with active disease.
- Chronic corticosteroid use may impair endothelial function in patients with stable disease.
Takeaway
This study found that corticosteroids can help or hurt blood vessel function in people with Behçet's disease, depending on whether their disease is active or not.
Methodology
A case-control, cross-sectional study assessing endothelial function via flow mediated dilatation in 87 patients with Behçet's disease and a prospective study of 11 patients before and after corticosteroid treatment.
Potential Biases
Potential bias due to the observational nature of the study and the lack of randomization.
Limitations
The study did not control for all cardiovascular risk factors and had a limited number of patients in the prospective study.
Participant Demographics
Patients aged 17 to 71 years, with a mix of active and inactive Behçet's disease.
Statistical Information
P-Value
0.003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website